key: cord-0785745-aox5dqxn
authors: Haehner, A.; Draf, J.; Draeger, S.; de With, K.; Hummel, T.
title: Predictive value of sudden olfactory loss in the diagnosis of COVID-19
date: 2020-05-03
journal: nan
DOI: 10.1101/2020.04.27.20081356
sha: a3b32b300ff4802a16708db87b2def4644bc7818
doc_id: 785745
cord_uid: aox5dqxn

Introduction: Recent reports suggest that sudden smell loss might be a symptom of SARS-CoV-2 infection. The aim of this study was to investigate the frequency of olfactory loss in an out-patient population who presented to a coronavirus testing center during a 2-week period and to evaluate the diagnostic value of the symptom sudden smell loss for screening procedures. Methods: In this cross-sectional controlled cohort study, 500 patients who presented with symptoms of a common cold to a corona testing center and fulfilled corona testing criteria, completed a standardized diagnostic questionnaire which included the patients main symptoms, time course and an additional self-assessment of the patients current smell, taste function and nasal breathing compared to the level before onset of symptoms. Results: Out of the 500 patients, 69 presented with olfactory loss. Twenty-two of them subsequently tested positive for SARS-CoV-2. Only twelve out of the patients without olfactory loss tested positive, resulting in a frequency of 64.7% for the symptom sudden smell loss in COVID-19 patients. Compared to COVID-19 patients without smell loss, they were significantly younger and less severely affected. Changes in nasal airflow were significantly more pronounced in SARS-CoV-2 negative patients with olfactory complaints compared to the patients with smell loss who were tested positive for SARS-CoV-2. By excluding patients with a blocked nose, the symptom sudden smell loss can be attested a high specificity (97%) and a sensitivity of 65% with a PPV of 63% and NPV of 97% for COVID-19. Conclusion: Considering the high frequency of smell loss in non-hospitalized COVID-19 patients, acute olfactory impairment should be included in the WHO symptoms list and should be recognized as an early symptom of the disease. In contrast to other acute viral smell impairment, COVID-19 associated smell loss seems to be only rarely accompanied by a severely blocked nose.

Viral upper respiratory tract infections (URTI) are one of the most common causes of olfactory loss. 2 Together with rhinoviruses, adeno-, influenza-, and parainfluenza viruses, coronaviruses have long 3 been known to account for at least 70% of common colds [1] . Compared to other respiratory 4 viruses however, the frequency of reported olfactory disorders in coronavirus infections was lower 5 so far and has never been a serious health issue [2,3,4]. 6 During an acute URTI, nasal congestion and rhinorrhea are commonly accompanied by a temporary 7 smell loss of varying severity. Significant olfactory loss without rhinitic symptoms however, is 8 comparatively rare and points towards damage of the olfactory epithelium. URTI-associated smell 9 loss typically occurs after the fifth decade of life and becomes apparent to the patients several days studies, a different pattern is seen in patients with severe acute respiratory syndrome coronavirus 2 1 2 (SARS-CoV-2) infection. Smell and/or taste loss have been observed in 5-80% of these patients 1 3

[6,7], sometimes as the only apparent symptom, at a younger age, and a very early stage of the 1 4 disease. The diagnostic accuracy of this symptom is controversially discussed considering the fact 1 5 that more than 200 viruses are known to cause URTIs with a subsequent olfactory loss.

The aim of this study was to investigate the frequency of olfactory loss in an out-patient population 1 7 who presented to a coronavirus testing center during a 2-week period and to evaluate the diagnostic 1 8 value of this symptom for screening procedures. All patients who presented to the coronavirus testing center at the University hospital Dresden function and nasal breathing compared to the level before onset of symptoms. The patients had to 2 5 All rights reserved. No reuse allowed without permission.

was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint (which this version posted May 3, 2020. 

Study population 1 1 Out of the 500 patients (mean age, 41.3 years; range, 18-86 years) who presented with symptoms of 1 2 a common cold (mean duration, 5.8 days; range, 1-32 days) and fulfilled corona testing criteria, (13.8%) reported sudden smell and/or taste loss. sure about the smell loss onset. COVID 19 patients with olfactory loss were significantly younger 2 2 than COVID-19 patients without smell loss (p=0.04) and had less severe symptoms (Table 1) .

Smell loss in COVID 19 patients was characterized by a severe loss of function from an average of 2 4 All rights reserved. No reuse allowed without permission.

was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint (which this version posted May 3, 2020. (Table 1) . 1 1 Disease-associated changes in nasal airflow were significantly more pronounced in the 47 SARS- function were rated more severe in the latter group (p=0.023). Predictive value (PV) 1 7 Using our data of an out-patient population, the sole symptom "smell loss" had the following sample however, positive PV increased to 63% and specificity to 97%. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint (which this version posted May 3, 2020. . https://doi.org/10.1101/2020. 04.27.20081356 doi: medRxiv preprint In this large URTI patient cohort study of a coronavirus testing center, we found that 13% of 1 patients reported sudden olfactory loss. Out of these patients, 32% were subsequently tested 2 positive for SARS-CoV-2. On the other hand, 2.8% of the patients without olfactory loss were 3 tested positive.

In this out-patient sample, 64.7% of COVID-19 patients observed smell and/or taste loss early or 5 even before other symptoms started. Compared to COVID-19 patients without smell loss they were 6 significantly younger and less severely affected. In contrast to other acute viral smell impairment, 7 COVID-19 associated smell loss seems to be only rarely accompanied by a severely blocked nose 8 and thus the effect on olfaction may be independent of nasal congestion. By excluding patients with 9 a blocked nose, the symptom "sudden smell loss" can be attested a high specificity (97%) and 1 0 sensitivity of 65% with a PPV of 63% and NPV of 97% for COVID-19. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint (which this version posted May 3, 2020. There is no sponsorship or funding arrangement related to this research. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

The common cold

An epidemiological study of postviral olfactory 3 disorder

Post-infectious 5 olfactory dysfunction exhibits a seasonal pattern

Identification of viruses in 7 patients with postviral olfactory dysfunction

All rights reserved. No reuse allowed without permission.was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which this version posted May 3, 2020. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which this version posted May 3, 2020.